Financial Ratios

JUPITER BIOSCIENCE LTD.

NSE : NABSE : 524826ISIN CODE : INE918B01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE3.970 (0 %)
PREV CLOSE ( ) 3.97
OPEN PRICE ( ) 4.06
BID PRICE (QTY) 4.11 (2390)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 230737
TODAY'S LOW / HIGH ( )3.89 4.14
52 WK LOW / HIGH ( ) 3.894.14
NSE
This Company is not listed in NSE
Select year
ParticularsMar2011Mar2010Mar2009Mar2008Mar2007
Operational & Financial Ratios
   Earnings Per Share (Rs)6.0220.5417.4714.9119.08
   CEPS(Rs)13.1542.3633.7324.4732.43
   DPS(Rs)1.002.002.002.002.25
   Book NAV/Share(Rs)116.08191.61172.60149.05120.20
   Tax Rate(%)5.8711.1012.1313.8126.14
Margin Ratios
   Core EBITDA Margin(%)43.3751.9651.3445.0043.58
   EBIT Margin(%)25.8632.8534.6332.6231.04
   Pre Tax Margin(%)15.7820.2722.4524.1724.49
   PAT Margin (%)14.8518.0219.7220.8318.09
   Cash Profit Margin (%)32.4337.1638.0834.1830.75
Performance Ratios
   ROA(%)3.694.664.896.216.56
   ROE(%)7.2711.2810.2713.9118.58
   ROCE(%)6.819.079.3910.9113.35
   Asset Turnover(x)0.250.260.250.300.36
   Sales/Fixed Asset(x)0.510.460.470.630.81
   Working Capital/Sales(x)1.741.451.481.651.83
Efficiency Ratios
   Fixed Capital/Sales(x)1.952.162.111.591.24
   Receivable days77.5381.1790.6081.8174.57
   Inventory Days91.34108.06118.16107.7698.67
   Payable days20.1428.9936.6722.9323.31
Valuation Parameters
   PER(x)3.304.062.159.657.56
   PCE(x)1.511.971.115.884.45
   Price/Book(x)0.170.440.220.971.20
   Yield(%)5.042.405.331.391.56
   EV/Net Sales(x)2.072.852.363.462.94
   EV/Core EBITDA(x)4.775.494.457.546.72
   EV/EBIT(x)8.028.696.8110.629.46
   EV/CE(x)0.420.670.530.870.87
   M Cap / Sales0.490.730.422.011.37
Growth Ratio
   Net Sales Growth(%)37.6028.7010.1124.8230.11
   Core EBITDA Growth(%)14.9426.3026.9031.2928.83
   EBIT Growth(%)8.3022.1116.8931.1423.78
   PAT Growth(%)13.4417.574.2743.709.78
   EPS Growth(%)-70.6917.5717.19-21.85-1.35
Financial Stability Ratios
   Total Debt/Equity(x)0.561.270.990.701.39
   Current Ratio(x)6.0911.736.214.714.03
   Quick Ratio(x)3.736.713.532.682.23
   Interest Cover(x)2.572.612.843.864.74
   Total Debt/Mcap(x)3.262.934.570.731.29

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.